These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 30113227)

  • 1. Early airway microbial metagenomic and metabolomic signatures are associated with development of severe bronchopulmonary dysplasia.
    Lal CV; Kandasamy J; Dolma K; Ramani M; Kumar R; Wilson L; Aghai Z; Barnes S; Blalock JE; Gaggar A; Bhandari V; Ambalavanan N
    Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L810-L815. PubMed ID: 30113227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The airway microbiome of intubated premature infants: characteristics and changes that predict the development of bronchopulmonary dysplasia.
    Lohmann P; Luna RA; Hollister EB; Devaraj S; Mistretta TA; Welty SE; Versalovic J
    Pediatr Res; 2014 Sep; 76(3):294-301. PubMed ID: 24941215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Airway Microbial Community Turnover Differs by BPD Severity in Ventilated Preterm Infants.
    Wagner BD; Sontag MK; Harris JK; Miller JI; Morrow L; Robertson CE; Stephens M; Poindexter BB; Abman SH; Mourani PM
    PLoS One; 2017; 12(1):e0170120. PubMed ID: 28129336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of new biomarkers of bronchopulmonary dysplasia using metabolomics.
    Piersigilli F; Lam TT; Vernocchi P; Quagliariello A; Putignani L; Aghai ZH; Bhandari V
    Metabolomics; 2019 Feb; 15(2):20. PubMed ID: 30830433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tracheal aspirate VEGF and sphingolipid metabolites in the preterm infant with later development of bronchopulmonary dysplasia.
    Hendricks-Muñoz KD; Xu J; Voynow JA
    Pediatr Pulmonol; 2018 Aug; 53(8):1046-1052. PubMed ID: 29687638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Airway Microbiome and Development of Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review.
    Pammi M; Lal CV; Wagner BD; Mourani PM; Lohmann P; Luna RA; Sisson A; Shivanna B; Hollister EB; Abman SH; Versalovic J; Connett GJ; Bhandari V; Ambalavanan N
    J Pediatr; 2019 Jan; 204():126-133.e2. PubMed ID: 30297287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low serum IGF-1 and increased cytokine levels in tracheal aspirate samples are associated with bronchopulmonary dysplasia.
    Yılmaz C; Köksal N; Özkan H; Dorum BA; Bağcı O
    Turk J Pediatr; 2017; 59(2):122-129. PubMed ID: 29276864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlates of Elevated Interleukin-6 and 8-Hydroxy-2'-Deoxyguanosine Levels in Tracheal Aspirates from Very Low Birth Weight Infants Who Develop Bronchopulmonary Dysplasia.
    Hsiao CC; Chang JC; Tsao LY; Yang RC; Chen HN; Lee CH; Lin CY; Tsai YG
    Pediatr Neonatol; 2017 Feb; 58(1):63-69. PubMed ID: 27321203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbial signatures in amniotic fluid at preterm birth and association with bronchopulmonary dysplasia.
    Staude B; Gschwendtner S; Frodermann T; Oehmke F; Kohl T; Kublik S; Schloter M; Ehrhardt H
    Respir Res; 2023 Oct; 24(1):248. PubMed ID: 37845700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Microbiome of the Lower Respiratory Tract in Premature Infants with and without Severe Bronchopulmonary Dysplasia.
    Imamura T; Sato M; Go H; Ogasawara K; Kanai Y; Maeda H; Chishiki M; Shimizu H; Mashiyama F; Goto A; Momoi N; Hosoya M
    Am J Perinatol; 2017 Jan; 34(1):80-87. PubMed ID: 27240094
    [No Abstract]   [Full Text] [Related]  

  • 11. Ceramides in tracheal aspirates of preterm infants: Marker for bronchopulmonary dysplasia.
    van Mastrigt E; Zweekhorst S; Bol B; Tibboel J; van Rosmalen J; Samsom JN; Kroon AA; de Jongste JC; Reiss IKM; Post M; Pijnenburg MW
    PLoS One; 2018; 13(1):e0185969. PubMed ID: 29346372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary metabolomics of bronchopulmonary dysplasia (BPD): preliminary data at birth suggest it is a congenital disease.
    Fanos V; Pintus MC; Lussu M; Atzori L; Noto A; Stronati M; Guimaraes H; Marcialis MA; Rocha G; Moretti C; Papoff P; Lacerenza S; Puddu S; Giuffrè M; Serraino F; Mussap M; Corsello G
    J Matern Fetal Neonatal Med; 2014 Oct; 27 Suppl 2():39-45. PubMed ID: 25284176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Airway Microbiome and Metabolome in Preterm Infants: Potential Biomarkers of Bronchopulmonary Dysplasia.
    Xu Q; Yu J; Liu D; Tan Q; He Y
    Front Pediatr; 2022; 10():862157. PubMed ID: 35620149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevation of interleukin-8 and interleukin-6 precedes the influx of neutrophils in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia.
    Munshi UK; Niu JO; Siddiq MM; Parton LA
    Pediatr Pulmonol; 1997 Nov; 24(5):331-6. PubMed ID: 9407566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Airway nitrite is increased in extremely preterm infants with bronchopulmonary dysplasia.
    Gentle SJ; Freeman A; Patel RP; Ambalavanan N; Lal CV
    Respir Res; 2020 Sep; 21(1):244. PubMed ID: 32957939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Untargeted Metabolomic Analysis of Amniotic Fluid in the Prediction of Preterm Delivery and Bronchopulmonary Dysplasia.
    Baraldi E; Giordano G; Stocchero M; Moschino L; Zaramella P; Tran MR; Carraro S; Romero R; Gervasi MT
    PLoS One; 2016; 11(10):e0164211. PubMed ID: 27755564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomal microRNA predicts and protects against severe bronchopulmonary dysplasia in extremely premature infants.
    Lal CV; Olave N; Travers C; Rezonzew G; Dolma K; Simpson A; Halloran B; Aghai Z; Das P; Sharma N; Xu X; Genschmer K; Russell D; Szul T; Yi N; Blalock JE; Gaggar A; Bhandari V; Ambalavanan N
    JCI Insight; 2018 Mar; 3(5):. PubMed ID: 29515035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolome and microbiome multi-omics integration from a murine lung inflammation model of bronchopulmonary dysplasia.
    El Saie A; Fu C; Grimm SL; Robertson MJ; Hoffman K; Putluri V; Ambati CSR; Putluri N; Shivanna B; Coarfa C; Pammi M
    Pediatr Res; 2022 Dec; 92(6):1580-1589. PubMed ID: 35338351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Gut Microbiota Changes in Preterm Infants with Bronchopulmonary Dysplasia: A Pilot Case-Control Study.
    Chen SM; Lin CP; Jan MS
    Am J Perinatol; 2021 Sep; 38(11):1142-1149. PubMed ID: 32446254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exhaled breath condensate nitrite in premature infants with bronchopulmonary dysplasia.
    Yen E; Weinberger BI; Laumbach RJ; Ohman-Strickland PA; Vetrano AM; Gow AM; Ramagopal M
    J Neonatal Perinatal Med; 2018; 11(4):399-407. PubMed ID: 30040745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.